StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Panacea Life Sciences's operating cash flow for the twelve months ending Mar 31, 2024 was -$1.57M. For fiscal 2023 it was -$1.52M. The highest annual figure on record is -$399.65K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.52M–
FY2022Dec 31, 2022-$2.40M–
FY2021Dec 31, 2021-$3.92M–
FY2020Dec 31, 2020-$7.65M–
FY2019Dec 31, 2019-$5.75M–
FY2018Dec 31, 2018-$465.76K–
FY2017Dec 31, 2017-$1.23M–
FY2016Dec 31, 2016-$890.96K–
FY2015Dec 31, 2015-$640.02K–
FY2014Dec 31, 2014-$399.65K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$357.09K–
Q4 FY2023Dec 31, 2023$1.57K–
Q3 FY2023Sep 30, 2023-$728.87K–
Q2 FY2023Jun 30, 2023-$483.32K–
Q1 FY2023Mar 31, 2023-$313.85K–
Q4 FY2022Dec 31, 2022-$523.00K–
Q3 FY2022Sep 30, 2022-$711.08K–
Q2 FY2022Jun 30, 2022-$729.46K–
Q1 FY2022Mar 31, 2022-$436.04K–
Q4 FY2021Dec 31, 2021-$1.23M–
Q3 FY2021Sep 30, 2021-$752.50K–
Q2 FY2021Jun 30, 2021-$1.14M–
Q1 FY2021Mar 31, 2021-$795.23K–
Q4 FY2020Dec 31, 2020-$1.03M–
Q3 FY2020Sep 30, 2020-$600.35K–
Q2 FY2020Jun 30, 2020-$5.85M–
Q1 FY2020Mar 31, 2020-$164.28K–
Q4 FY2019Dec 31, 2019-$718.62K–
Q3 FY2019Sep 30, 2019-$1.54M–
Q2 FY2019Jun 30, 2019-$1.65M–
Q1 FY2019Mar 31, 2019-$1.83M–
Q4 FY2018Dec 31, 2018-$57.83K–
Q3 FY2018Sep 30, 2018-$73.92K–
Q2 FY2018Jun 30, 2018-$38.73K–
Q1 FY2018Mar 31, 2018-$295.28K–
Q4 FY2017Dec 31, 2017-$30.80K–
Q3 FY2017Sep 30, 2017-$93.89K–
Q2 FY2017Jun 30, 2017-$326.80K–
Q1 FY2017Mar 31, 2017-$783.43K–
Q4 FY2016Dec 31, 2016-$406.82K–
Q3 FY2016Sep 30, 2016-$129.28K–
Q2 FY2016Jun 30, 2016-$188.32K–
Q1 FY2016Mar 31, 2016-$166.54K–
Q4 FY2015Dec 31, 2015-$69.14K–
Q1 FY2015Mar 31, 2015-$81.16K–
Q4 FY2014Dec 31, 2014-$289.52K–
Q3 FY2014Sep 30, 2014-$15.13K–

More Panacea Life Sciences figures

See a number that looks wrong?